Paula Ragan
Fortune : 481 981 $ au 31/05/2026
Fortune : 481 981 $ au 31/05/2026
Paula S.
Ragan was the founder of X4 Pharmaceuticals, Inc., founded in 2014, holding titles including President, Chief Executive Officer & Director, and President, CEO, Co-Secretary & Director.
Former jobs include President, CEO, Secretary & Director at Arsanis, Inc.; Senior Director-Corporate Development at Oscient Pharmaceuticals Corp.; Independent Director at CAMP4 Therapeutics Corp.
from 2019 to 2025; Principal at Pfizer Inc., St. Lawrence Energy Corp., and Celera Group; Head-Corporate Development & Operations at Genzyme Corp.
from 2007 to 2012; and Chief Business Officer at Lysosomal Therapeutics, Inc. from 2012 to 2014.
Education includes a doctorate from Massachusetts Institute of Technology, an undergraduate degree from Tufts University, and a doctorate from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2026 | 91 221 ( 0,1% ) | 393 163 $ | 31/05/2026 | |
| 25/06/2025 | 20 232 ( 0,04% ) | 88 818 $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Directeur/Membre du Conseil | 09/09/2025 |
| X4 PHARMACEUTICALS, INC. | Fondateur | 12/08/2025 |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Corporate Officer/Principal | 01/09/2014 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/08/2012 |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
St. Lawrence Energy Corp.
St. Lawrence Energy Corp. SemiconductorsElectronic Technology Develops & markets advanced photo voltaic solar products | Electronic Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national